Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/6/26 18:05 | 2/4/26 | SLDB | Health | BioPrd | Biological Products, (No Diag | Howton David T | MA | O | COO | 5 | S.dm | -390 | 1.99 | 0 | -196 | 117 | D | |||||||||||||||
2/6/26 18:01 | 2/4/26 | SLDB | Health | BioPrd | Biological Products, (No Diag | Cumbo Alexander | MA | DO | P,CEO | 5 | S.dm | -887 | 2.02 | 0 | -438 | 271 | D | |||||||||||||||
2/6/26 18:01 | 2/4/26 | SLDB | Health | BioPrd | Biological Products, (No Diag | Ganot Ilan | MA | D | 6 | S.d | -53 | 1.74 | 0 | -31 | 151 | I | ||||||||||||||||
2/6/26 18:00 | 2/4/26 | SLDB | Health | BioPrd | Biological Products, (No Diag | Tan Kevin | MA | O | CFO,Trea | 5 | S.dm | -298 | 2.01 | 0 | -148 | 109 | D | |||||||||||||||
2/6/26 17:59 | 2/4/26 | SLDB | Health | BioPrd | Biological Products, (No Diag | Brooks Gabriel | MA | O | Chief Me | 3 | S.dm | -264 | 2.06 | 0 | -128 | 97 | D | |||||||||||||||
2/6/26 17:57 | 2/4/26 | SLDB | Health | BioPrd | Biological Products, (No Diag | Hanrahan Jessie | MA | O | Chief Re | 5 | S.dm | -273 | 1.98 | 0 | -138 | 83 | D | |||||||||||||||
2/6/26 17:56 | 2/4/26 | SLDB | Health | BioPrd | Biological Products, (No Diag | Herzich Paul | MA | O | CTO | 5 | S.dm | -253 | 2.00 | 0 | -127 | 80 | D | |||||||||||||||
1/7/26 16:05 | 1/6/26 | SLDB | Health | BioPrd | Biological Products, (No Diag | Smith Ian F | MA | D | 1 | M.d | 0 | 0.00 | 0 | 5 | 4 | 131 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |